Medivis Receives FDA 510(k) Clearance for Spine Navigation and Announces Commercial Launch in the United States

NEW YORK, April 2, 2025 /PRNewswire/ — Medivis Inc., a pioneer in surgical intelligence, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Spine Navigation platform. This milestone marks a significant advancement in surgical technology, utilizing AR and AI to empower surgeons with holographic navigation across open and minimally invasive spine procedures. Alongside the FDA clearance, Medivis is announcing the commercial launch of Spine Navigation, making it available to hospitals and ambulatory surgical centers nationwide.

“Surgery is entering a new era of advanced computing that enhances precision, speed, and efficiency in the operating room. This is a pivotal moment in medicine, and we are thrilled to deliver a solution that will elevate patient care to new heights,” said Dr. Christopher Morley, President of Medivis.

“At Medivis, we envision a future where surgical navigation transcends boundaries by integrating imaging data with the operative field. With our recent FDA clearance for Spine Navigation, we are thrilled to equip surgeons with breakthrough technology to visually transform spine surgery and empower them with intuitive image guidance,” added Dr. Osamah Choudhry, CEO of Medivis.

Medivis’ Spine Navigation platform is applicable across neurosurgery and orthopedic surgery. Its key strengths include:

  • Surgical Intelligence: Combining proprietary computer vision algorithms, AI segmentation, real-time data analysis and advanced image processing to deliver precise, context-aware insights throughout the surgical workflow.
  • Ergonomic Freedom: Lightweight AR hardware allows surgeons to visualize critical information with unmatched comfort while operating. Hand tracking and voice commands grant complete control of the environment, eliminating attention-shift away from the operative field.
  • Seamless Integration: Minimal-footprint workstation paired with intuitive instrumentation allows Medivis’ technology to integrate with spinal hardware and imaging systems across major commercial vendors. It is built for easy deployment in operating rooms, including in ambulatory surgical centers.

Spine Navigation is the latest addition to the company’s portfolio of AI-powered surgical solutions, which are designed to transform the operating room and enhance surgical precision across a range of specialties.

About Medivis
Medivis is a leading surgical intelligence company dedicated to pioneering the future of surgical navigation with artificial intelligence and augmented reality. To learn more, visit www.medivis.com.

Contact: brooke@medivis.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medivis-receives-fda-510k-clearance-for-spine-navigation-and-announces-commercial-launch-in-the-united-states-302418834.html

SOURCE Medivis

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

3 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

3 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago